MPO and colitis: While we have previously reported that MPO inhibition via pharmacological intervention using either cyclic nitroxides (4-methoxy-TEMPO) or 2-thioxanthines (AZD3421) ameliorates DSS-induced colitis, we now report that MPO KO mice showed poor colitis outcomes during acute experimental colitis [11,12].